A novel multi-epitope peptide vaccine against cancer: an in silico approach
From MaRDI portal
Publication:2632772
DOI10.1016/J.JTBI.2014.01.018zbMATH Open1412.92157OpenAlexW2083157454WikidataQ45853904 ScholiaQ45853904MaRDI QIDQ2632772FDOQ2632772
Authors: Navid Nezafat, Younes Ghasemi, Gholamreza Javadi, Mohammad Javad Khoshnoud, Eskandar Omidinia 
Publication date: 15 May 2019
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2014.01.018
Recommendations
- Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells
- Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules
- Computational modeling of the immune response to tumor antigens
- Knowledge-based virtual screening of HLA-A*0201-restricted CD8\(^+\) T-cell epitope peptides from herpes simplex virus genome
- On immunotherapies and cancer vaccination protocols: a mathematical modelling approach
Cited In (3)
- Knowledge-based virtual screening of HLA-A*0201-restricted CD8\(^+\) T-cell epitope peptides from herpes simplex virus genome
- Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein
- Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules
Uses Software
This page was built for publication: A novel multi-epitope peptide vaccine against cancer: an in silico approach
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2632772)
